Scinopharm Taiwan Ltd, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A leading process R&D and API Manufacturing service provider to the Global Pharmaceutical Industry.
One of their notable products is ONDANSETRON HYDROCHLORIDE USP, with a corresponding US DMF Number 15990.
Remarkably, this DMF maintains an Active status since its submission on May 27, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 25, 2020, and payment made on February 20, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II